Animal Models for Basic and Preclinical Research in Bladder Cancer

作者: Ana Mara , Catalina Lodillinsky , Eduardo Omar

DOI: 10.5772/28580

关键词:

摘要: Bladder cancer is one of the most common cancers in world. In 2006, there were about 61,240 diagnosed cases bladder and approximately 13,060 deaths attributable to this disease, being prevalence estimated worldwide more than 1,000,000 patients (Jemal et al., 2006; Lerner, 2005). Taking into account that its incidence seems be increasing, clearly a significant public health issue around Thus, it necessary intensify research on topic. Urinary originates mainly from epithelial cells urothelium (LopezBeltran 2004; Montironi When initially diagnosed, (about 70%) do not present muscle invasion, are thus known as non-muscle invasive (pTa pT1). these cases, simple transurethral resection sufficient remove tumor. However, some experience recurrence or even tumor progression. The progression involves invasion cells, which penetrate deeper layers such detrusor (pT2), perivesical tissue (pT3) extravesical organs (pT4) (Figure 1). Since threatens patient's life, aggressive therapies (Sobin 1997). Intensive cancer, well tumors, carried out elucidate reason for appearance find factors involved their development related process. These investigations, provide insights biology tumor, essential implementation new therapeutic and/or preventive modalities (Bhattacharya 2010; Zhang 2011). Research basic science focused mechanisms lead towards transformation using experimental models where easier interpret results. Cell culture techniques widely used study different oncological processes. cell growth any type, usually with nutrient-containing solutions. grow attached plastic surface, forming monolayer, two-dimensional way. This technique allows studying processes mutagenesis, migration, production proteolytic enzymes. Although very important tool, has certain limitations. Many biological depend three-dimensional architecture. addition, monolayer

参考文章(76)
Claire L. Varley, Jennifer Southgate, Organotypic and 3D reconstructed cultures of the human bladder and urinary tract Methods of Molecular Biology. ,vol. 695, pp. 197- 211 ,(2011) , 10.1007/978-1-60761-984-0_13
Woo Sung Moon, Sook Kim, Hyun Jin Son, Ho Sung Park, [The role of angiostatin, vascular endothelial growth factor, matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma]. The Korean Journal of Hepatology. ,vol. 10, pp. 62- 72 ,(2004)
Gingrich, Smaldone Mc, Gayed Ba, Tomaszewski Jj, Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer. The Italian journal of urology and nephrology. ,vol. 61, pp. 71- 89 ,(2009)
Ronald A. Lubet, Gary J. Kelloff, Alane T. Koki, Clinton J. Grubbs, Karen Seibert, D. L. Hill, Vernon E. Steele, Jaime L. Masferrer, Kathleen M. Leahy, Celecoxib Inhibits N-Butyl-N-(4-hydroxybutyl)-nitrosamine-induced Urinary Bladder Cancers in Male B6D2F1 Mice and Female Fischer-344 Rats Cancer Research. ,vol. 60, pp. 5599- 5602 ,(2000)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Ronald A Lubet, Clinton J Grubbs, Reid R Townsend, James P Malone, Pengyuan Liu, Ming You, Weidong Wen, Yan Lu, Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models. American Journal of Translational Research. ,vol. 3, pp. 8- 27 ,(2011)
Susan Fuggle, Roy Bicknell, David Cranston, Tim O'Brien, Adrian L. Harris, Different Angiogenic Pathways Characterize Superficial and Invasive Bladder Cancer Cancer Research. ,vol. 55, pp. 510- 513 ,(1995)
Mike Bradburn, Tim O'Brien, Sue Fuggle, Jeremy P. Crew, Roy Bicknell, David Cranston, Adrian L. Harris, Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Research. ,vol. 57, pp. 5281- 5285 ,(1997)
Peter C. Black, Anil Shetty, Gordon A. Brown, Emilio Esparza-Coss, Adam R. Metwalli, Piyush K. Agarwal, David J. McConkey, John D. Hazle, Colin P.N. Dinney, Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis BJUI. ,vol. 106, pp. 1799- 1804 ,(2010) , 10.1111/J.1464-410X.2010.09424.X
David J. McConkey, Daniel J. Hicklin, Darren W. Davis, Keiji Inoue, Colin P.N. Dinney, Robert Radinsky, Takashi Karashima, Joel W. Slaton, Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel Clinical Cancer Research. ,vol. 6, pp. 2635- 2643 ,(2000)